Profiel
Stephen M Hahn is the Chief Executive Officer at Nucleus Radiopharma, Inc. since 2025.
Mr. Hahn is also a Director at Ion Beam Applications SA since 2026.
Mr. Hahn completed undergraduate education at William Marsh Rice University and graduate education at Temple University (Pennsylvania).
Actieve functies van Stephen Hahn
| Bedrijven | Functie | Begin |
|---|---|---|
| ION BEAM APPLICATIONS, SA | Directeur/Bestuurslid | 16-06-2026 |
Nucleus Radiopharma, Inc.
Nucleus Radiopharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a end-to-end contract development and manufacturing organization | Algemeen Directeur | 20-08-2025 |
Opleiding van Stephen Hahn
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 4 |
|---|---|
Ion Beam Applications SA
Ion Beam Applications SA Medical SpecialtiesHealth Technology Supplies medical, dental and hospital equipment | Health Technology |
Rice University
Rice University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Temple University (Pennsylvania)
Temple University (Pennsylvania) Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Nucleus Radiopharma, Inc.
Nucleus Radiopharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a end-to-end contract development and manufacturing organization | Health Technology |
















